GO
Loading...
 

Biotech: 2014's favored child

Thu 16 Jan 14 | 12:15 PM ET
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

Biotech: 2014's favored child

Thu 16 Jan 14 | 12:15 PM ET
Mark Schoenebaum, ISI Group analyst, breaks down the red hot biotech sector and explains why Gilead Sciences is his best play.
 
RELATED ARTICLES AND CONTENT
More Videos
Latest Videos
Stock Pops & Drops: CSX, YHOO, TWTR, CTRL
Wed 16 Apr 14 | 05:45 PM ET
Latest Videos
Yahoo CEO Mayer earned $24.9 million in 2013
Wed 16 Apr 14 | 05:31 PM ET
Latest Videos
Awaiting pricing of Weibo
Wed 16 Apr 14 | 05:25 PM ET
Latest Videos
Thinking inside the 'Box'
Wed 16 Apr 14 | 05:21 PM ET
Go
Displaying results for: Latest Video | US